Allergan Profit Margin 2006-2018 | AGN

Current and historical gross margin, operating margin and net profit margin for Allergan (AGN) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Allergan net profit margin as of September 30, 2018 is 14.5%.
Allergan Annual Profit Margins
Allergan Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $55.271B $15.941B
Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan plc, formerly known as Actavis plc, is headquartered in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $24.090B 7.38
Mylan (MYL) United Kingdom $18.532B 7.63
Bausch Health Cos (BHC) Canada $9.165B 6.64
Dr Reddy's Laboratories (RDY) India $5.542B 22.13
Mallinckrodt Public Limited Company (MNK) United Kingdom $2.633B 4.39
Supernus Pharmaceuticals (SUPN) United States $2.334B 22.13
Amphastar Pharmaceuticals (AMPH) United States $0.971B 105.00
Akorn (AKRX) United States $0.845B 0.00
Homology Medicines (FIXX) United States $0.749B 0.00
CymaBay Therapeutics (CBAY) United States $0.624B 0.00
Assembly Biosciences (ASMB) United States $0.581B 0.00
Corium (CORI) United States $0.457B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.443B 0.00
Voyager Therapeutics (VYGR) United States $0.375B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.313B 0.00
Teligent (TLGT) United States $0.165B 0.00
Sol-Gel Technologies (SLGL) Israel $0.131B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.100B 0.00
Aevi Genomic Medicine (GNMX) United States $0.081B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.053B 0.00
Evoke Pharma (EVOK) United States $0.046B 0.00
Acasti Pharma (ACST) Canada $0.045B 0.00
Agile Therapeutics (AGRX) United States $0.031B 0.00
China Pharma Holdings (CPHI) China $0.013B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.009B 0.00